948 Results

People

  1. Kris
    Kris
  2. Kelsen
    Kelsen
  3. Motzer
    Motzer
  4. O'Reilly
    O'Reilly
  5. Saltz
    Saltz
  6. Tyson
    Tyson
  7. Gralla
    Gralla
  8. Hudis
    Hudis
  9. Scher
    Scher
  10. Aghajanian
    Aghajanian

Groups

  1. Department of Medicine (633)
  2. Solid Tumor Oncology Division (507)
  3. Gastrointestinal Oncology Service (138)
  4. Survivorship Research (128)
  5. Hematologic Malignancies, Division of (127)
  6. Thoracic Oncology (112)
  7. Center for Hematologic Malignancies (109)
  8. Genitourinary Oncology Service (106)
  9. Nursing (101)
  10. Surgery (97)
  1. "vomiting"
Formats
  1. Journal Article (896)
  2. Review (27)
  3. Conference Paper (8)
  4. Editorial (6)
  5. Research Letter (4)
  6. Correspondence (2)
  7. Guidelines (2)
  8. Book Section (1)
  9. Meeting Abstract (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (633)
  2. Solid Tumor Oncology Division (507)
  3. Gastrointestinal Oncology Service (138)
  4. Survivorship Research (128)
  5. Hematologic Malignancies, Division of (127)
  6. Thoracic Oncology (112)

More Groups

People
  1. Mark Kris (70)
  2. David Kelsen (40)
  3. Robert Motzer (39)
  4. Eileen O'Reilly (30)
  5. Leonard Saltz (30)
  6. Leslie Tyson (28)

More People

Years
  1. 2025 (25)
  2. 2024 (63)
  3. 2023 (44)
  4. 2022 (32)
  5. 2021 (15)
  6. 2020 (50)

More Years

Publications
  1. Journal of Clinical Oncology (90)
  2. Cancer (47)
  3. Clinical Cancer Research (44)
  4. Lancet Oncology (38)
  5. Gynecologic Oncology (31)
  6. Cancer Treatment Reports (26)

More Publications

Publishers
  1. Elsevier Inc. (145)
  2. American Society of Clinical Oncology (92)
  3. Elsevier Science, Inc. (74)
  4. Springer (72)
  5. Oxford University Press (64)
  6. Wiley Blackwell (63)

More Publishers

Results (948)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML
    Journal Article

    Perl, A. E.; Martinelli, G.; Cortes, J. E.; Neubauer, A.; Berman, E.; Paolini, S.; Montesinos, P.; Baer, M. R.; Larson, R. A.; Ustun, C.; more...
    New England Journal of Medicine (2019)

    Fulltext@MSK | Save
  • Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): A phase 3, multicentre, open-label, single-arm trial
    Journal Article

    Fleseriu, M.; Pivonello, R.; Elenkova, A.; Salvatori, R.; Auchus, R. J.; Feelders, R. A.; Geer, E. B.; Greenman, Y.; Witek, P.; Cohen, F.; more...
    Lancet Diabetes & Endocrinology (2019)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: Extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
    Journal Article

    Motzer, R. J.; Rini, B. I.; McDermott, D. F.; Arén Frontera, O.; Hammers, H. J.; Carducci, M. A.; Salman, P.; Escudier, B.; Beuselinck, B.; Amin, A.; more...
    Lancet Oncology (2019)

    Fulltext@MSK | Save
  • Neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer
    Editorial

    Broderick, S. R.; Bott, M. J.
    Journal of Thoracic and Cardiovascular Surgery (2019)

    Fulltext@MSK | Save
  • Reduced-dose radiation therapy to the primary site is effective for high-risk neuroblastoma: Results from a prospective trial
    Journal Article

    Casey, D. L.; Kushner, B. H.; Cheung, N. K. V.; Modak, S.; Basu, E. M.; Roberts, S. S.; LaQuaglia, M. P.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • Effect of aging and predonation comorbidities on the related peripheral blood stem cell donor experience: Report from the Related Donor Safety Study
    Journal Article

    Pulsipher, M. A.; Logan, B. R.; Chitphakdithai, P.; Kiefer, D. M.; Riches, M. L.; Rizzo, J. D.; Anderlini, P.; Leitman, S. F.; Varni, J. W.; Kobusingye, H.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Maribavir for refractory or resistant cytomegalovirus infections in hematopoietic-cell or solid-organ transplant recipients: A randomized, dose-ranging, double-blind, phase 2 study
    Journal Article

    Papanicolaou, G. A.; Silveira, F. P.; Langston, A. A.; Pereira, M. R.; Avery, R. K.; Uknis, M.; Wijatyk, A.; Wu, J.; Boeckh, M.; Marty, F. M.; more...
    Clinical Infectious Diseases (2019)

    Fulltext@MSK | Save
  • A phase I/Ib trial of the VEGFR-sparing multikinase RET inhibitor RXDX-105
    Journal Article

    Drilon, A.; Fu, S.; Patel, M. R.; Fakih, M.; Wang, D.; Olszanski, A. J.; Morgensztern, D.; Liu, S. V.; Cho, B. C.; Bazhenova, L.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Classification of the acute emetogenicity of chemotherapy in pediatric patients: A clinical practice guideline
    Guidelines

    Paw Cho Sing, E.; Robinson, P. D.; Flank, J.; Holdsworth, M.; Thackray, J.; Freedman, J.; Gibson, P.; Orsey, A. D.; Patel, P.; Phillips, R.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • PARP inhibitors in older patients with ovarian and breast cancer: Young International Society of Geriatric Oncology review paper
    Review

    Liposits, G.; Loh, K. P.; Soto-Perez-de-Celis, E.; Dumas, L.; Battisti, N. M. L.; Kadambi, S.; Baldini, C.; Banerjee, S.; Lichtman, S. M.
    Journal of Geriatric Oncology (2019)

    Fulltext@MSK | Save